LAUSR

.. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. . have been reported with platelet function test or genotype-guided de-escalation from potent P2Y12 inhibitors to clopidogrel. 7 To conclude, aspirin withdrawal, in the context of other de-escalation strategies, is an emerging approach for the treatment of high-risk patients. Extrapolating these findings to a broader population than the one being studied, however, needs confirmation by ongoing and future investigations. Additional considerations related to drug resistance, patient preference, therapy non-compliance, and side effects, must play a role in the selection of the best treatment for the individual patient.